Historical record - last NADAC effective date: 1/18/2023
This NDC is on FDA's drug shortage list (posted Jan 19, 2023)
Reported reason: Discontinuation of the manufacture of the drug
Product Information
QUINAPRIL 5 MG TABLET is a generic product labeled by Aurobindo Pharma Limited, priced at $0.0753 per EA under NDC 65862061790. Its NADAC has been published 529 times since Nov 28, 2013.
FDA first approved this application on Apr 29, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Aurobindo Pharma LimitedNDC
65862061790
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
1/18/2023
Active Ingredients
QUINAPRIL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202725FDA Approved
4/29/2013
TE Code
AB
On Market Since
4/29/2013
Pharmacological Classes
Price Statistics
The NADAC for QUINAPRIL 5 MG TABLET has been published 529 times since Nov 28, 2013, and over the history we have for it it has declined 51.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0753 per EA |
|---|---|
| All-time high | $0.1630 (Jun 11, 2014) |
| All-time low | $0.0643 (Sep 21, 2022) |
| Median price | $0.1255 |
| Average price | $0.1225 |
| Largest weekly change | +58.9% (Oct 19, 2022) |
| Weeks tracked | 529 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
0.0%
5Y
-28.4%
All
-51.6%
Last surveyed Jan 10, 2024 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Quinapril Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUINAPRIL 5 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUINAPRIL 5 MG TABLET, manufactured by Aurobindo Pharma Limited, is $0.0753 per EA (NDC 65862061790), effective Jan 10, 2024.
How has the price of QUINAPRIL 5 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUINAPRIL 5 MG TABLET has declined 51.6%. It has been tracked across 529 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for QUINAPRIL 5 MG TABLET?
Since Nov 28, 2013, the NADAC for QUINAPRIL 5 MG TABLET has ranged from a low of $0.0643 (Sep 21, 2022) to a high of $0.1630 (Jun 11, 2014), with a median of $0.1255 per EA.
Are there cheaper alternatives to QUINAPRIL 5 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of QUINAPRIL 5 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures QUINAPRIL 5 MG TABLET?
QUINAPRIL 5 MG TABLET (NDC 65862061790) is labeled by Aurobindo Pharma Limited, and CMS classifies it as a generic product.
Is QUINAPRIL 5 MG TABLET in shortage?
Yes — NDC 65862061790 is currently listed in FDA's drug shortage database (posted Jan 19, 2023). Reported reason: Discontinuation of the manufacture of the drug.